A detailed history of New England Research & Management, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, New England Research & Management, Inc. holds 23,168 shares of ZTS stock, worth $4.14 Million. This represents 2.12% of its overall portfolio holdings.

Number of Shares
23,168
Previous 23,168 -0.0%
Holding current value
$4.14 Million
Previous $4.02 Million 12.72%
% of portfolio
2.12%
Previous 1.93%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$145.54 - $178.83 $280,164 - $344,247
-1,925 Reduced 7.67%
23,168 $4.02 Million
Q1 2024

Apr 16, 2024

BUY
$165.67 - $199.94 $252,646 - $304,908
1,525 Added 6.47%
25,093 $4.25 Million
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $202,929 - $268,120
1,340 Added 6.03%
23,568 $4.65 Million
Q3 2023

Oct 10, 2023

BUY
$167.14 - $192.77 $664,381 - $766,260
3,975 Added 21.78%
22,228 $3.87 Million
Q2 2023

Jul 05, 2023

BUY
$160.94 - $186.23 $185,081 - $214,164
1,150 Added 6.72%
18,253 $3.14 Million
Q1 2023

Apr 06, 2023

BUY
$145.48 - $175.02 $29,095 - $35,004
200 Added 1.18%
17,103 $2.85 Million
Q4 2022

Jan 09, 2023

SELL
$131.14 - $157.47 $39,341 - $47,241
-300 Reduced 1.74%
16,903 $2.48 Million
Q3 2022

Oct 06, 2022

BUY
$148.29 - $182.55 $177,948 - $219,060
1,200 Added 7.5%
17,203 $2.55 Million
Q2 2022

Jul 20, 2022

SELL
$155.97 - $200.09 $18,716 - $24,010
-120 Reduced 0.74%
16,003 $2.75 Million
Q1 2022

Apr 20, 2022

SELL
$181.39 - $234.03 $31,743 - $40,955
-175 Reduced 1.07%
16,123 $3.04 Million
Q4 2021

Jan 05, 2022

SELL
$193.69 - $247.03 $47,260 - $60,275
-244 Reduced 1.48%
16,298 $3.98 Million
Q3 2021

Oct 08, 2021

SELL
$189.29 - $209.69 $4,921 - $5,451
-26 Reduced 0.16%
16,542 $3.21 Million
Q2 2021

Jul 15, 2021

SELL
$155.9 - $187.99 $1,091 - $1,315
-7 Reduced 0.04%
16,568 $3.09 Million
Q1 2021

Apr 16, 2021

SELL
$144.0 - $169.39 $10,224 - $12,026
-71 Reduced 0.43%
16,575 $2.61 Million
Q4 2020

Jan 07, 2021

SELL
$157.07 - $174.35 $59,215 - $65,729
-377 Reduced 2.21%
16,646 $2.76 Million
Q3 2020

Oct 08, 2020

SELL
$137.1 - $165.37 $23,992 - $28,939
-175 Reduced 1.02%
17,023 $2.82 Million
Q2 2020

Jul 15, 2020

SELL
$111.92 - $142.53 $50,364 - $64,138
-450 Reduced 2.55%
17,198 $2.36 Million
Q1 2020

Jun 15, 2020

BUY
$92.66 - $144.94 $16,215 - $25,364
175 Added 1.0%
17,648 $2.08 Million
Q4 2019

Jan 14, 2020

SELL
$116.25 - $133.25 $11,625 - $13,325
-100 Reduced 0.57%
17,473 $2.31 Million
Q3 2019

Nov 04, 2019

SELL
$112.57 - $128.43 $56,285 - $64,215
-500 Reduced 2.77%
17,573 $2.19 Million
Q1 2019

Apr 03, 2019

SELL
$81.56 - $100.67 $36,702 - $45,301
-450 Reduced 2.43%
18,073 $1.82 Million
Q4 2018

Jan 11, 2019

SELL
$79.28 - $95.27 $71,352 - $85,743
-900 Reduced 4.63%
18,523 $1.58 Million
Q3 2018

Oct 03, 2018

SELL
$83.5 - $93.23 $12,525 - $13,984
-150 Reduced 0.77%
19,423 $1.78 Million
Q2 2018

Jul 05, 2018

SELL
$79.9 - $89.2 $33,957 - $37,910
-425 Reduced 2.13%
19,573 $1.67 Million
Q1 2018

Apr 17, 2018

SELL
$71.51 - $84.69 $23,240 - $27,524
-325 Reduced 1.6%
19,998 $1.67 Million
Q4 2017

Jan 09, 2018

SELL
$63.24 - $72.8 $638,407 - $734,916
-10,095 Reduced 33.19%
20,323 $1.46 Million
Q3 2017

Oct 25, 2017

BUY
$59.73 - $65.4 $1.82 Million - $1.99 Million
30,418
30,418 $1.94 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.